Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimation of shielding factors for linear accelerators.

James Mechalakos1, Jean St Germain

  • 1Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 , USA. mechalaj@mskcc.org

Health Physics
|December 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation-Free Adaptive Prostate Stereotactic Body Radiation Therapy on Magnetic Resonance-Linac: Technical Feasibility and Clinical Experience.

International journal of radiation oncology, biology, physics·2026
Same author

Risk analysis of the Unity 1.5T MR-Linac adapt-to-shape workflow.

Journal of applied clinical medical physics·2025
Same author

Deformable Image Registration Uncertainty-Encompassing Dose Accumulation for Adaptive Radiation Therapy.

International journal of radiation oncology, biology, physics·2025
Same author

An automated technique for global noise level measurement in CT image with a conjunction of image gradient.

Physics in medicine and biology·2024
Same author

Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial.

JAMA network open·2023
Same author

Risk analysis of the Unity 1.5 T MR-Linac adapt-to-position workflow.

Journal of applied clinical medical physics·2022

New radiotherapy techniques like intensity-modulated radiation therapy (IMRT) may increase workload, but standard shielding calculations remain sufficiently conservative. This study suggests current assumptions may not require substantive changes for radiation therapy shielding.

Area of Science:

  • Medical Physics
  • Radiation Oncology

Background:

  • Modern radiotherapy techniques, including intensity-modulated radiation therapy (IMRT) and multi-leaf collimation (MLC), are increasingly used in cancer treatment.
  • These advanced techniques may alter radiation treatment room workloads compared to older methods.
  • Existing radiation shielding calculations are based on assumptions about these workloads.

Purpose of the Study:

  • To evaluate the actual workloads in a large radiation oncology department.
  • To determine if current workload assumptions used for shielding calculations are still adequate with modern techniques.
  • To assess the need for revising standard shielding calculation methodologies.

Main Methods:

  • Workload data was collected from treatment rooms in a large hospital department.

Related Experiment Videos

  • Data encompassed various treatment machines with differing energies and techniques, including IMRT and MLC.
  • Analysis focused on comparing measured workloads against standard assumptions for shielding design.
  • Main Results:

    • The study examined workloads in a department with diverse treatment machines and techniques.
    • Preliminary data suggests that existing assumptions for shielding calculations may be overly conservative.
    • The observed workloads, even with advanced techniques, might not necessitate significant changes to current shielding practices.

    Conclusions:

    • Standard assumptions used in radiation shielding calculations appear to remain sufficiently conservative.
    • Despite the increased use of advanced techniques like IMRT and MLC, substantive revisions to shielding calculations may not be immediately required.
    • Further investigation with larger sample sizes is warranted to confirm these findings across different clinical settings.